Familial atypical hemolytic uremic syndrome: a review of its genetic and clinical aspects.
Clin Dev Immunol. 2012; 2012: 370426
Genetic studies into inherited and sporadic hemolytic uremic syndrome.
Kidney Int. 1998; 53: 836-844
Haemolytic uraemic syndrome.
Lancet. 2017; 390: 681-696
Glomerular diseases dependent on complement activation, including atypical hemolytic uremic syndrome, membranoproliferative glomerulonephritis, and C3 glomerulopathy: core curriculum.
Am J Kidney Dis. 2015; 66: 359-375
Anti-complement-factor H-associated glomerulopathies.
Nat Rev Nephrol. 2016; 12: 563-578
Factors determining penetrance in familial atypical haemolytic uraemic syndrome.
J Med Genet. 2014; 51: 756-764
Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32.
Hum Mol Genet. 2005; 14: 703-712
European Working Party on Complement Genetics in Renal Diseases. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.
J Am Soc Nephrol. 2013; 24: 475-486
Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome.
Proc Natl Acad Sci USA. 2007; 104: 240-245
Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.
Clin J Am Soc Nephrol. 2013; 8: 554-562
Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome.
Nat Genet. 2013; 45: 531-536
Complement mutations in diacylglycerol kinase-epsilon-associated atypical hemolytic uremic syndrome.
Clin J Am Soc Nephrol. 2014; 9: 1611-1619
A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation.
J Am Soc Nephrol. 2015; 26: 209-219
A novel hybrid CFHR1/CFH gene causes atypical hemolytic uremic syndrome.
Pediatr Nephrol. 2013; 28: 2221-2225
Atypical haemolytic uraemic syndrome associated with a hybrid complement gene.
Plos Med. 2006; 3: e431
A novel deletion in the RCA gene cluster causes atypical hemolytic uremic syndrome.
Nephrol Dial Transpl. 2011; 26: 739-741
C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation.
J Clin Invest. 2013; 123: 2434-2446
Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis.
Lancet. 2010; 376: 794-801
Complement factor H-related hybrid protein deregulates complement in dense deposit disease.
J Clin Invest. 2014; 124: 145-155
Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees.
Clin J Am Soc Nephrol. 2011; 6: 1436-1446
Deficiency in two brothers with atypical dense intramembranous deposit disease.
Kidney Int. 1986; 30: 949-956
Human factor H deficiency. Mutations in framework cysteine residues and block in H protein secretion and intracellular catabolism.
J Biol Chem. 1997; 272: 25168-25175
Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation.
J Clin Invest. 2010; 120: 3702-3712
A familial C3GN secondary to defective C3 regulation by complement receptor 1 and complement factor H.
J Am Soc Nephrol. 2016; 27: 1665-1677
Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.
Kidney Int. 2012; 82: 454-464
High-throughput genetic testing for thrombotic microangiopathies and C3 glomerulopathies.
J Am Soc Nephrol. 2016; 27: 1245-1253
Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome.
Mol Immunol. 2016; 71: 131-142
Current concepts in C3 glomerulopathy.
Indian J Nephrol. 2014; 24: 339-348
Statistical validation of rare complement variants provides insights into the molecular basis of atypical hemolytic uremic syndrome and C3 glomerulopathy.
J Immunol. 2018; 200: 2464-2478
Exome Aggregation C: analysis of protein-coding genetic variation in 60,706 humans.
Nature. 2016; 536: 285-291
New functional and structural insights from updated mutational databases for complement factor H, Factor I, membrane cofactor protein and C3.
Biosci Rep. 2014; 34: e00146
An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations.
Hum Mutat. 2006; 27: 21-30
Molecular modelling of mutations in the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site.
J Mol Biol. 2002; 316: 217-224
Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.
Genet Med. 2017; 19: 192-203
Rare variant association studies: considerations, challenges and opportunities.
Genome Med. 2015; 7: 16
Structure of complement fragment C3b-factor H and implications for host protection by complement regulators.
Nat Immunol. 2009; 10: 728-733
Structural basis for sialic acid-mediated self-recognition by complement factor H.
Nat Chem Biol. 2015; 11: 77-82
Electrostatic interactions contribute to the folded-back conformation of wild type human factor H.
J Mol Biol. 2009; 391: 98-118
Structures of complement component C3 provide insights into the function and evolution of immunity.
Nature. 2005; 437: 505-511
Structural basis for complement factor I control and its disease-associated sequence polymorphisms.
Proc Natl Acad Sci USA. 2011; 108: 12839-12844
Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens.
Plos Pathog. 2010; 6: e1001122
Two distinct conformations of factor H regulate discrete complement-binding functions in the fluid phase and at cell surfaces.
J Biol Chem. 2018; 293: 17166-17187
Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses.
Nat Struct Mol Biol. 2017; 24: 643-651
Crystal structure of a tripartite complex between C3dg, C-terminal domains of factor H and OspE of Borrelia burgdorferi.
PLoS One. 2017; 12: e0188127
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “kidney disease: Improving Global outcomes” (KDIGO) Controversies conference.
Kidney Int. 2017; 91: 539-551